A detailed history of Blue Fin Capital, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Blue Fin Capital, Inc. holds 19,300 shares of JNJ stock, worth $3.13 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
19,300
Previous 19,254 0.24%
Holding current value
$3.13 Million
Previous $3.05 Million 7.39%
% of portfolio
0.57%
Previous 0.68%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$144.38 - $157.78 $6,641 - $7,257
46 Added 0.24%
19,300 $2.82 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $26,542 - $27,828
-171 Reduced 0.88%
19,254 $3.05 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $183,601 - $200,347
-1,261 Reduced 6.1%
19,425 $3.04 Million
Q3 2023

Oct 19, 2023

BUY
$155.75 - $174.48 $20,559 - $23,031
132 Added 0.64%
20,686 $3.22 Million
Q2 2023

Jul 31, 2023

SELL
$154.35 - $166.11 $7,254 - $7,807
-47 Reduced 0.23%
20,554 $3.4 Million
Q1 2023

May 12, 2023

SELL
$151.05 - $180.26 $17,370 - $20,729
-115 Reduced 0.56%
20,601 $3.19 Million
Q4 2022

Jan 23, 2023

SELL
$160.2 - $179.79 $40,210 - $45,127
-251 Reduced 1.2%
20,716 $0
Q3 2022

Nov 04, 2022

BUY
$161.33 - $179.52 $107,123 - $119,201
664 Added 3.27%
20,967 $3.43 Million
Q2 2022

Aug 08, 2022

SELL
$168.19 - $186.01 $12,109 - $13,392
-72 Reduced 0.35%
20,303 $3.6 Million
Q1 2022

Apr 12, 2022

BUY
$158.14 - $179.59 $38,744 - $43,999
245 Added 1.22%
20,375 $3.61 Million
Q4 2021

Jan 19, 2022

SELL
$155.93 - $173.01 $65,178 - $72,318
-418 Reduced 2.03%
20,130 $3.44 Million
Q3 2021

Oct 25, 2021

SELL
$161.5 - $179.47 $18,895 - $20,997
-117 Reduced 0.57%
20,548 $3.32 Million
Q2 2021

Jul 19, 2021

SELL
$159.48 - $171.07 $71,606 - $76,810
-449 Reduced 2.13%
20,665 $3.4 Million
Q1 2021

May 05, 2021

BUY
$153.07 - $170.48 $23,725 - $26,424
155 Added 0.74%
21,114 $3.47 Million
Q4 2020

Jan 28, 2021

BUY
$137.11 - $157.38 $250,362 - $287,375
1,826 Added 9.54%
20,959 $3.3 Million
Q3 2020

Oct 28, 2020

SELL
$140.38 - $153.83 $299,149 - $327,811
-2,131 Reduced 10.02%
19,133 $2.85 Million
Q2 2020

Aug 10, 2020

BUY
$128.81 - $155.51 $338,641 - $408,835
2,629 Added 14.11%
21,264 $2.99 Million
Q1 2020

Apr 28, 2020

BUY
$111.14 - $153.99 $2,000 - $2,771
18 Added 0.1%
18,635 $2.44 Million
Q4 2019

Feb 10, 2020

SELL
$127.5 - $146.44 $23,205 - $26,652
-182 Reduced 0.97%
18,617 $2.71 Million
Q3 2019

Nov 07, 2019

SELL
$126.95 - $142.14 $148,658 - $166,445
-1,171 Reduced 5.86%
18,799 $2.43 Million
Q2 2019

Jul 22, 2019

BUY
$131.15 - $144.24 $24,525 - $26,972
187 Added 0.95%
19,970 $2.78 Million
Q1 2019

Apr 23, 2019

SELL
$125.72 - $139.79 $27,406 - $30,474
-218 Reduced 1.09%
19,783 $2.77 Million
Q4 2018

Jan 16, 2019

SELL
$122.84 - $147.84 $57,366 - $69,041
-467 Reduced 2.28%
20,001 $2.58 Million
Q3 2018

Nov 09, 2018

SELL
$121.58 - $142.88 $3,768 - $4,429
-31 Reduced 0.15%
20,468 $2.83 Million
Q2 2018

Aug 06, 2018

SELL
$119.4 - $131.76 $22,089 - $24,375
-185 Reduced 0.89%
20,499 $2.49 Million
Q1 2018

May 07, 2018

BUY
$125.1 - $148.14 $113,841 - $134,807
910 Added 4.6%
20,684 $2.65 Million
Q4 2017

Jan 26, 2018

SELL
$131.22 - $143.62 $4,067 - $4,452
-31 Reduced 0.16%
19,774 $2.76 Million
Q3 2017

Oct 11, 2017

BUY
$129.47 - $135.38 $2.56 Million - $2.68 Million
19,805
19,805 $2.57 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $424B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Blue Fin Capital, Inc. Portfolio

Follow Blue Fin Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Fin Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Fin Capital, Inc. with notifications on news.